Viralgen Partners with Elaaj Bio to Advance Gene Therapy Program for CDKL5 Deficiency Disorder
Collaboration leverages AAV manufacturing expertise to advance a preclinical-stage gene therapy program for a rare pediatric neurological disorder. SAN SEBASTIÁN, Spain and LONDON, May 5, 2026 /PRNewswire/ — Viralgen, a leading contract
